Skip to main content
Marine Drugs logoLink to Marine Drugs
. 2017 Nov 1;15(11):338. doi: 10.3390/md15110338

Isolation and Characterization of Polysaccharides from Oysters (Crassostrea gigas) with Anti-Tumor Activities Using an Aqueous Two-Phase System

Kit-Leong Cheong 1,, Li-Xuan Xia 1,, Yang Liu 1,*
PMCID: PMC5706028  PMID: 29104211

Abstract

In this study, a simple aqueous two-phase system (ATPS) was employed for concurrent purification of oyster polysaccharides. The chemical structure and anti-tumor activities of purified oyster polysaccharides (OP-1) were also investigated. Under optimal ATPS conditions, oyster polysaccharides can be partitioned in the bottom phase with 67.02% extraction efficiency. The molecular weight of OP-1 was determined as 3480 Da. OP-1 is a (1→4)-α-d-glucosyl backbone and branching points located at O-3 of glucose with a terminal-d-Glcp. The anti-tumor activity assay showed that OP-1 exhibited good activities, including promotion of splenocyte proliferation, IL-2 release, and inhibition of HepG2 cell proliferation. Additionally, OP-1 had no in vivo toxicity. This finding suggests that ATPS is a much simpler and greener system, and it opens up new possibilities in the large-scale separation of active polysaccharides from oysters. OP-1 could be used by the health food and pharmaceutical therapies as potential anti-cancer adjuvants.

Keywords: Crassostrea gigas, polysaccharides, aqueous two-phase system, anti-tumor activity

1. Introduction

Pacific oysters (Crassostrea gigas) are the largest molluscan group cultured in China. They grow fast and spread quickly due to their good tolerance of environmental alterations [1]; this feature has helped them become an abundant ocean-derived resource. Pacific oysters are referred to as “the milk of the sea” because they are an excellent source of high-quality nutrition, which include polysaccharides, protein, peptides, lipids, phenolic compounds, and minerals [2,3]. In addition to their nutritional value, oysters could be utilized as potential functional food exhibiting beneficial health effects. Oysters are an adequate resource with high functional value; therefore, they have much potential in the functional food industry.

Functional studies have been conducted on oyster polysaccharides, including the potential interleukin-2 (IL-2) effects on peripheral blood mononuclear cells [4], modulation of antigen-induced splenocyte proliferation and T-cell cytokine expression [5], and enhancement of the phenoloxidase activity of hemocyte suspensions [6]. Recently, some bioactive polysaccharides have been isolated from oysters and have shown hepatoprotective [7], anti-hypertensive [8], and other anti-oxidant activities [9]. Usually, polysaccharides’ biological activities are closely correlated to their molecular mass, chemical structure, monosaccharide composition, and linkage type [10,11]. Therefore, a better understanding of oyster polysaccharides’ chemical structures and physical properties is essential for the successful interpretation of the correlation between the structure and bioactivity of these molecules and would also be beneficial for the future application of these types of polysaccharides in functional food areas.

Polysaccharides are a type of biomacromolecule that have wide applications in functional food, pharmaceutical, and industrial research fields. The method by which pure polysaccharides are effectively obtained is the basis of studies on this subject. The traditional methods for polysaccharide purification include ethanol precipitation, de-proteinization by the Sevag method, and ion-exchange and size exclusion chromatography [12,13]. However, these conventional methods are time-consuming, have laborious procedures and high operating costs, and involve organic solvents. An aqueous two-phase extraction system (ATPS) is a liquid–liquid separation technique based on the formation of two immiscible water-rich phases above certain critical concentrations of two mutually incompatible solutes [14]. ATPS has been successfully used to separate and purify flavonoids [15], small organic molecules [16], DNA [17], proteins [18,19], and polysaccharides [20] from fruits, plants, and herbs. APTSs are environmentally friendly, low-cost, easy to operate, and high in efficiency, and they have been used to separate and purify bioactive polysaccharides on a large scale in a single step. The most commonly explored type of ATPS in recent years for separation of polysaccharide/proteins is the polymer–salt system. High-molecular-weight hyaluronic acid was purified with a polyethylene glycol/potassium phosphate system, and nearly all of the hyaluronic acid in the salt-rich bottom phase and its purity reached almost 100% [21]. Xing and Li purified the aloe from bovine serum albumin with a PEG6000/(NH4)2SO4 system, and partitioned the aloe polysaccharides in the bottom phase. This phase separation and partitioning behaviour of aloe polysaccharides may be influenced by NaCl, pH, and Gu(SCN)2 [22]. A polymer-salt system consisting of ethylene-oxide-β-propylene-oxide-β-ethylene-oxide and NaH2PO4 was used to partition the Lycium barbarum extract. The L. barbarum polysaccharides were partitioned to the bottom phase with a high recovery ratio and purity [23].

In this study, a simple ATPS was employed to separate polysaccharides and proteins produced by Pacific oysters. The partitioning efficiency of polysaccharides and proteins and the influences of different processing parameters (such as composition and molecular mass of PEG) were analyzed in detail. The chemical structures and biological activities of the purified polysaccharides were also analyzed in detail. The results could be helpful in further understanding the structure–function relationship of these polysaccharides, and could pave the way for the potential use of oyster polysaccharides as functional foods or therapeutic agents.

2. Results and Discussion

2.1. Selection of the Optimal Aqueous Two-Phase System

To determine the optimal ATPS, the partitioning of oyster polysaccharides and proteins in ATPS at room temperature was investigated. The test systems are shown in Table 1. PEG/ammonium sulfate with different compositions and constant volume ratios were used. It can be seen that oyster polysaccharides were enriched in the bottom phase. A high polysaccharide extraction efficiency (about 71.84–89.42%) was found in the bottom phase of the PEG-1000/ammonium sulfate system. At the same time, the protein was also found in the bottom phase with an extraction efficiency of 64.43–83.38%. In the PEG-4000/ammonium sulfate system, the tie line length (TLL) increment caused a shift in the protein from the bottom to the top phase. The PEG-4000/ammonium sulfate system (2.2102 g:0.1319 g, w/w) with a TLL of 45 showed a relatively low protein extraction efficiency (about 15.59%) with a high polysaccharide concentration, and it showed that a large portion of protein was enriched in the top phase after the phase separation process. However, it may lose about 30.09% of polysaccharides in the top phase.

Table 1.

Effect of different compositions of PEG, ethanol and ammonium sulfate, tie line length, and volume ratio on oyster polysaccharide content in aqueous two-phase systems.

Composition (w/w) Tie Line Length Volume Ratio Recovery of Polysaccharides (%) Recovery of Protein (%)
Top Phase Bottom Phase Top Phase Bottom Phase
PEG-1000 AS a
0.2270 0.1764 30 1.02 ± 0.01 5.71 ± 0.31 83.88 ± 0.19 14.68 ± 0.25 83.38 ± 0.31
0.2348 0.1796 35 1.06 ± 0.04 6.92 ± 0.17 73.25 ± 0.27 8.59 ± 0.07 77.76 ± 0.25
0.2432 0.1834 40 1.03 ± 0.01 8.16 ± 0.28 89.42 ± 0.33 11.83 ± 0.12 55.47 ± 0.33
0.2520 0.1876 45 1.04 ± 0.02 8.92 ± 0.10 71.84 ± 0.32 20.09 ± 0.12 72.23 ± 0.23
0.2613 0.1923 50 1.03 ± 0.02 8.61 ± 0.13 72.60 ± 0.21 18.67 ± 0.27 64.43 ± 0.29
PEG-2000 AS
0.1524 0.1153 30 1.06 ± 0.03 8.79 ± 0.22 69.61 ± 0.17 5.71 ± 0.22 83.88 ± 0.45
0.1697 0.1228 35 1.04 ± 0.04 6.25 ± 0.13 49.08 ± 0.23 6.92 ± 0.25 73.25 ± 0.33
0.1870 0.1306 40 1.02 ± 0.01 5.93 ± 0.05 29.50 ± 0.39 8.16 ± 0.09 89.42 ± 0.37
0.2045 0.1389 45 1.03 ± 0.02 5.55 ± 0.09 37.84 ± 0.26 3.92 ± 0.01 81.84 ± 0.31
0.2221 0.1477 50 1.02 ± 0.02 9.67 ± 0.14 36.02 ± 0.31 2.61 ± 0.01 72.60 ± 0.47
PEG-4000 AS
0.1721 0.1102 30 1.03 ± 0.02 14.68 ± 0.17 83.38 ± 0.39 12.74 ± 0.01 52.64 ± 0.31
0.1841 0.1167 35 1.06 ± 0.04 8.59 ± 0.16 77.76 ± 0.43 12.77 ± 0.05 67.35 ± 0.22
0.1966 0.1238 40 1.05 ± 0.04 18.20 ± 0.08 73.46 ± 0.32 8.24 ± 0.01 52.86 ± 0.30
0.2102 0.1319 45 1.02 ± 0.02 30.09 ± 0.23 62.23 ± 0.28 36.26 ± 0.13 15.59 ± 0.27
0.2238 0.1404 50 1.05 ± 0.02 38.67 ± 0.32 54.43 ± 0.19 35.62 ± 0.16 10.44 ± 0.04
Ethanol AS
0.1770 0.2729 35 1.05 ± 0.03 12.12 ± 0.11 67.02 ± 0.33 25.01 ± 0.11 18.13 ± 0.29
0.1844 0.2749 40 1.02 ± 0.01 13.47 ± 0.18 65.35 ± 0.21 23.92 ± 0.34 21.28 ± 0.17
0.1930 0.2776 45 1.04 ± 0.01 12.24 ± 0.09 52.86 ± 0.44 44.69 ± 0.31 21.91 ± 0.13
0.2030 0.2811 50 1.04 ± 0.02 26.26 ± 0.37 45.59 ± 0.23 45.13 ± 0.42 22.08 ± 0.22
0.2120 0.2845 55 1.03 ± 0.03 25.62 ± 0.27 37.44 ± 0.23 45.62 ± 0.37 26.05 ± 0.21

a AS: ammonium sulfate.

The ethanol/ammonium sulfate system with different compositions was further investigated. It can be seen that the ethanol/ammonium sulfate system had lower protein recovery in the bottom phase when compared with the PEG/ammonium sulfate system (Table 1) because more protein was in the middle phase. Accordingly, with an increase in TLL, the recovery of polysaccharides in the bottom phase decreased because the strong salting-out effect led to an increase in salt concentration. The increase in salt concentration led to less available free water to dissolve the oyster polysaccharides, resulting in decreased polysaccharide recovery. Therefore, 0.1770 g of ethanol and 0.2729 g of ammonium sulfate were selected for oyster polysaccharide partitioning. About 67.02% of polysaccharides were obtained in the bottom phase, and only 12.12% of the polysaccharides were lost in the top phase. After phase separation, the bottom phase was collected and dialyzed against water for 24 h. The retentate in the dialysis bag (a molecular weight cut-off of 500 Da) was concentrated in a vacuum evaporator and then lyophilized to dryness (Figure 1).

Figure 1.

Figure 1

Flow chart of extraction, separation, and purification of polysaccharides from oysters using an aqueous two-phase system.

2.2. Purity and Homogeneity

The lyophilized purified polysaccharides were in the form of a white powder, named OP-1. The weight-average molecular weight (Mw) and purity were analyzed by high-performance gel-permeation chromatography (HPPGC). A homogeneous peak appeared in the HPGPC elution profile of OP-1, with an Mw based on a column calibration of 3480 Da.

2.3. Chemical Structures of the Purified Polysaccharides

The monosaccharide composition of OP-1 is only glucose, as detected through the high performance liquid chromatography (HPLC) coupled with an evaporative light scattering detector (ELSD) of the OP-1 hydrolysate. The glycosyl-linkage of OP-1 was identified through methylation analysis. The GC-MS of the alditol acetates from methylated OP-1 revealed the presence of 1,5-di-O-acetyl-2,3,4,6-tetra-O-methyl-d-glucitol, 1,4,5-tri-O-acetyl-2,3,6-tri-O-methyl-d-glucitol, and 1,3,4,5-tetra-O-acetyl-2,6-di-O-methyl-d-glucitol derivatives at a molar ratio of 1.3:9.5:1. These results indicated that OP-1 exhibited an (1→4)-linked backbone with branching points located at O-3 of Glcp with terminal-d-Glcp as a side chain. Meanwhile, the degree of branching was calculated as 24%, according to the Tao et al. report [24]: DB=(NT+NB)(NT+NB+NL), where NT, NB, and NL are the total numbers of the terminal residues, branched residues, and linear residues, respectively.

The spectra of 1H NMR and 13C NMR of OP-1 are shown in Figure 2. The values of the chemical shifts found in the NMR spectrum of OP-1 are summarized in Table 2. The anomeric protons of Residues A, B, and C had chemical shifts larger than δ 5.00, suggesting that these residues were α-linked. The presence of residues of α-linked residues was identical to that found via FTIR. The signal around δ 5.43 overlapped with broad peaks, suggesting that there were some branches in α-(1→4)-linked residues [25]. The up-field signals between δ 3.9 and δ 3.4 were attributed to the proton resonances of H-2 to H-6. The signals in the 13C NMR spectra indicated that all of the residues (A, B, and C) of OP-1 share an α anomeric configuration based on the fact that the chemical shifts of glucose is δ 100.0 [26]. A signal observed at δ 77.6 ppm was assigned to the resonance of C-4 of 4-linked-α-Glc.

Figure 2.

Figure 2

1H NMR (a), 13C NMR (b), HSQC (c), and HMBC (d) spectra of the OP-1 from oysters recorded in D2O at 27 °C. (e) The predicted structure of OP-1 isolated from the oyster.

Table 2.

1H NMR and 13C NMR chemical shifts (δ) of the OP-1 from the oyster recorded in D2O at 27 °C.

Residues Chemical Shifts 1H/13C (ppm)
1 2 3 4 5 6(a) 6(b)
A α-Glcp-(1→ 5.43 3.74 3.74 3.79 3.74 3.94 3.86
100.4 71.7 73.5 73.2 72.4 61
B α-(1→4)-Glcp 5.43 3.64 3.7 3.69 3.91 3.94 3.86
100.4 71.9 73.6 78 71.8 61
C α-(1→3,4)-Glcp 5.43 3.68 4.03 3.73 3.71 3.94 3.86
100.4 72.3 73.8 77.9 72.1 61

Underlined bold numbers represent glycosylation sites.

The HSQC (Figure 2c) and HMBC (Figure 2d) spectra of OP-1 provided anomeric intra-residue and inter-residue correlations, respectively. The HSQC technique provided correlations between the carbon and its attached protons (as listed in Table 2). The correlation signals can be employed as the starting point to completely assign all 1H and 13C signals of OP-1. Based on the HMBC interpretation, the chemical shifts of C-3, C-4, C-5, and C-6 of α-(1→4)-Glcp were assigned as δ 73.6, δ 78.0, δ 71.8, and δ 61.0, respectively. A down-field shift of signal of C-6 (δ 61.0), combined with the cross peak of δ 3.69 (H-4) with δ 78.0 in the HSQC spectrum, may indicate the presence of the α-Glcp-(1→ residues linked at the O-4 position. More structural information of OP-1 and the assignments of NMR resonances were recorded on the basis of analysis of HSQC and HMBC spectra. The inter-residue HMBC correlations from H-1 of residue A to C-4 of residue B (Figure 2d) indicated that the backbone of -[α-Glcp-(1→4)]- terminal linked with α-Glcp-(1→ residues. The linkage between Residues B and C was supported by the HMBC correlation of H-1 of Residue C with C-4 of Residue B (Figure 2d). Similarly, the cross-peak of H-1 (A) to C-3 (C) at δ 5.43/77.9, indicated that Residue A was substituted at the O-3 position of Residue C by side chains.

The NMR technique is a powerful tool for structural elucidation. However, it is limited and difficult to obtain the complete structure of polysaccharides by the interpretation of NMR spectra, for the NMR resonances of polysaccharides always overlap. Therefore, the proposed structure of OP-1 is mainly based on the data obtained from methylation and then further confirmed by NMR data. After comprehensive composition analysis, methylation analysis, and NMR experiments, it can be concluded that the repeating unit of OP-1 has a backbone of (1→4)-α-d-glucosyl residues, and has α-d-glucosyl residues on the terminal of the side chains at the O-3 position. The predicted structure of OP-1 is presented in Figure 2e.

More recently, the α-glucan from aquatic species showed interesting pharmacological activities has been attracting the attention of scientists seeking to explore new potent biological activities [27]. A water-soluble glucan isolated from Cyclina sinensis showed significant scavenging activities on superoxide radicals and an inhibitory effect in vitro on human gastric cancer cells [28]. A water-soluble α-glucan was isolated from foot muscle of Bellamya purificata by Zhang et al. [29], and significant anti-inflammatory activity was found. This glucan has a backbone of α-(1→4)-d-glucopyranosyl and branches at O-6 of α-(1→6)-d-glucopyranosyl residues [29]. Altogether, these data point to the idea that the α-glucan from mollusks contributes to the diversion of the immune host response.

2.4. Cell Proliferation and IL-2 Production

As the first step toward understanding the anti-tumor activity of OP-1, the effects of OP-1 on lymphocyte proliferation were investigated. As shown in Figure 3a, OP-1 was found to cause a dose-dependent increase at concentrations from 10 to 250 µg/mL in spleen lymphocyte cell proliferation. Cell proliferation was increased 64.44% when OP-1 at the concentration of 10 µg/mL, and ConA at the concentration of 5 µg/mL. The immune system plays a significant role in anti-tumor activity. Numerous reports have suggested that anti-tumor activity of the polysaccharides is mediated through a thymus-dependent immune mechanism [30]. Lymphocyte proliferation of splenocytes is a direct indicator of cellular immunity.

Figure 3.

Figure 3

(a) Effects of OP-1 on the viability of spleen lymphocyte. (b) Morphology of HepG2 cells under inverted microscope. (c) Effects of OP-1 on phagocytosis of HepG2 cells in vivo. Fluorescence microscopic image of HepG2 cells were incubated with FITC-labeled annexin V and PI. (d) Inhibitory effect of OP-1 on HepG2 cells. * p < 0.05; ** p < 0.01 vs. control.

The activated immune cells also secrete some cytokines, such as IL-1, IL-2, IL-6, TNF-α, and IFN-γ. The effects of OP-1 treatment on the secretion of IL-2 are listed in Table 3. The results showed that OP-1 could increase lymphocyte secretion of IL-2. A similar result was observed in a study by Cheng et al. [5], in which it was demonstrated that lymphocytes exposed to oyster polysaccharides significantly increased the production of IL-4 and IFN-γ. Thus, OP-1 may have an indirect role in anti-tumor activity through cell proliferation promotion and the release of the lymphocyte-produced effector molecule, IL-2.

Table 3.

Effect of oyster polysaccharides (OP-1) on IL-2 secretion via lymphocyte.

Sample IL-2 (pg/mL) SI (%)
Blank 167.09 ± 3.92
Con A 239.46 ± 3.28 43.31 ± 2.73
OP-1 439.80 ± 2.72 ** 149.87 ± 0.18 **

Mean ± SD; n = 3. ** p < 0.01 vs. control.

2.5. Cytotoxic Activity on HepG2 and Madin–Daby Canine Kidney (MDCK) Cell

After 24 h treatment with OP-1, human liver cancer HepG2 cells were examined by an inverted microscope. In Figure 3b, the number of cells in the OP-1 group obviously decreased when compared with the blank group (Figure 3b). OP-1 was shown to be dose-dependent on the inhibition of HepG2 cell proliferation (Table 4). At concentrations of 100 μg/mL and 200 μg/mL, the inhibitory ratios were 47.23% and 52.94%, respectively. In contrast to 5-fluorouracil (5-Fu), OP-1 had less anti-tumor activity on HepG2 cells (50.72% and 39.70%, respectively) when the same dose of OP-1 (25 μg/mL) was used.

Table 4.

Cytotoxicity of OP-1 at different concentrations against human liver cancer HepG2 cells and Madin–Daby canine kidney MDCK cells in vitro.

Concentration HepG2 Cells MDCK Cells
μg/mL 5-Fu OP-1 5-Fu OP-1
25 50.72 ± 0.71 39.70 ± 3.18 42.65 ± 1.31 −6.05 ± 0.96
50 46.20 ± 2.61 −4.50 ± 1.13
100 47.23 ± 2.03 −9.78 ± 4.00
150 52.24 ± 1.16 −14.01 ± 0.30 *
200 55.82 ± 2.03 −15.48 ± 6.65 **

Mean ± SD; n = 3. * p < 0.05; ** p < 0.01 vs. control.

The anti-tumor activity was further confirmed by a HepG2 phagocytic assay. Fluorescein isothiocyanate-conjugated (FITC)-labeled annexin V and propidium iodide (PI) uptake in HepG2 cells were compared between the positive control and the blank groups. HepG2 cells displayed phosphatidylserine on their outer cell membranes and were readily stained with annexin V in the early stages of apotosis. At later stages of apoptosis, PI moved across the cell membrane and bound to cellular DNA. Apoptotic cells could then be detected after they were double-stained with annexin V and PI. The results showed that OP-1 (15 µg/mL) could obviously enhance phagocytic activities, which displayed a higher FITC-fluorescence intensity when compared with the untreated control groups (Figure 3c,d).

Cytotoxicity assays for anti-tumor agents are important chemotherapeutic parameters. Therefore, cytotoxic effects were also determined in Madin–Daby canine kidney MDCK cells. OP-1 at doses of 25–250 μg/mL did not show cytotoxicity, while 5-Fu had a cytotoxic effect on MDCK cells (Table 4). The results suggest that OP-1 had no toxic effects at any of the tested concentrations.

Taking into account the increasing incidence of cancer in various organs, effective agents or compounds are urgently needed to control this problem. Most of the polysaccharides are considered to have a wide variety of biological activities. A brief review of recent advances in applications of polysaccharides derived from marine origin for pharmacological activities has been reported [31]. Over the last few decades, the functional food and pharmaceutical industries have shown a strong interest in polysaccharides derived from marine sources in general. The main reason for this increased interest is that polysaccharides are non-toxic, natural, less expensive, and abundantly available in nature. Therefore, oyster polysaccharides hold great promise as a potential source of new therapeutic agents.

Based on the above results describing its biological activities, OP-1 had significant anti-tumor activities against liver cancer and HepG2 cells and had no direct toxicity to the normal cells.

3. Materials and Methods

3.1. Materials

Acetic anhydride was purchased from Sigma-Aldrich (St. Louis, MO, USA). Dimethyl sulfoxide (DMSO; 99.9%) was purchased from Alfa Aesar (Ward Hill, MA, USA). Methyl iodide was purchased from VWR International (Lutterworth, UK). Other reagents were analytical grade.

3.2. Extraction of Polysaccharides from Oyster

Oyster meat was stripped from the shells, and then homogenized in a blender. The homogeneous mixture was extracted with water at 90 °C for 3 h. After cooling to room temperature, the extract was centrifuged at 4000× g for 15 min and the supernatant was collected. Total sugar content was determined by the phenol-sulfuric acid assay with glucose as the standard [32]. The protein concentration of each sample was determined by a BCA protein assay kit (Thermo Fisher Scientific Inc., Rockford, IL, USA).

3.3. Preparation of Aqueous Two-Phase Systems

Aqueous PEG/salt systems were prepared by weighing the appropriated amounts of PEG stock solution, ammonium sulfate stock solution, oyster extract, and water, to a final weight of 8 g, in order to achieve the desired composition. Ethanol/salt systems were prepared by weighing the appropriated amounts of ethanol, ammonium sulfate stock solution, oyster extract, and water to a final weight of 8 g. The two phases were mingled thoroughly and stood for 10 min, and the two phases were then completely separated. The partitioning experiments were carried out at room temperature.

The TLL was determined by the square root of the sum of the squares of the difference between the top and bottom phases. The volume ratio was obtained dividing the volume of top phase by the volume of the bottom phase. The extraction efficiency (E, %) was the concentration of the polysaccharides or proteins partitioned in the bottom phase to the amount of the sample added. The extraction efficiency was calculated with the following equation:

E (%)=Ct×Vtmo×100%

where Ct is the concentration of the upper phase, Vt is the volume of the upper phase, and mo is the amount of the sample added.

3.4. Chemical Characterization

3.4.1. Monosaccharide Composition Analysis

Polysaccharides (5 mg) were treated with 1 mol/L H2SO4 (2 mL) at 100 °C for 4 h. After hydrolysis, the mixture was neutralized with Ba(OH)2. The hydrolysate was detected by Agilent 1200 HPLC system (Agilent, Santa Clara, CA, USA) equipped with an ESLD (Alltech, Deerfield, IL, USA). Chromatographic separation was performed at 25 °C using a column of Prevail Carbohydrate ES column (250 mm × 4.6 mm, 5 μm, Alltech). The mobile phase consisted of acetonitrile and water (v/v, 75:25) at a flow rate of 1.0 mL/min. The drift tube temperature for ELSD was set at 83 °C, and the nitrogen flow rate was 2.1 L/min. The injection volume was 5 μL.

3.4.2. Methylation Analysis

Purified polysaccharides were methylated according to a previous report [33]. The polysaccharides (5 mg) were dissolved in DMSO (5 mL); subsequently, 20 mg of NaOH and 150 μL of CH3I were added. After reaction for 4 h in the dark, water and dichloromethane were then added. The dichloromethane layer was dried under vacuum at 50 °C. Subsequently, the residue was hydrolyzed with TFA for 6 h at 105 °C. The hydrolyzed product was also dried under vacuum at 50 °C, and the residue was subsequently reduced with NaBH4, neutralized with acetic acid, and acetylated with acetic anhydride to obtain a mixture of partially O-methylated alditol acetates. Qualitative and quantitative analyses were conducted using GC-MS.

3.4.3. 1H and 13C NMR Test

Purified polysaccharides (25 mg) were dissolved in 1 mL of D2O at room temperature. NMR spectra were recorded on a Bruker Avance 400 spectrometer (Bruker BioSpin, Billerica, MA, USA) at 400 MHz for 1H and 100 MHz for 13C.

3.5. Anti-Tumor Activities of Oyster Polysaccharide

3.5.1. Preparation of Spleen Lymphocytes

The extirpated spleens were minced into small pieces with knife and suspended in an RPMI 1640 medium. Single-cell suspension was filtered by a sterile sieve mesh. The cells were supplemented with 6 mL of lysis buffer to remove the red blood cells, and then washed 3 times with cold phosphate-buffered saline. Subsequently, the cells were adjusted to a concentration of 1 × 106 cells/mL in RPMI-1640 medium. The suspended cells were then collected.

3.5.2. Cell Proliferation Assay

Cells (1 × 104 cells/well) were treated with serial concentrations (10, 50, and 250 µg/mL) of OP-1 and 5.0 µg/mL ConA for 24 h, respectively. Cell culture RPMI-1640 medium was used as a blank group. Following incubation at 37 °C and 5% CO2, MTT (0.5 mg/mL) was added and co-incubated for an additional 4 h in the dark. After cultivation, the supernatants were removed, and the insoluble purple-colored formazan MTT was dissolved in sodium dodecyl sulfate lysis buffer (sodium dodecyl sulfate, isopropanol, and HCl). The absorbance values were recorded at 570 nm, and the cell viability was calculated as the percentage of the ratios of absorbance between the treated and blank groups.

3.5.3. Measurement of IL-2

Cells (1 × 106 cells/mL) were exposed to 250 µg/mL of OP-1 and 5.0 μg/mL ConA for 24 h at 37 °C and 5% CO2. After incubation, the cell supernatants were then collected via centrifugation at 1200× g for 5 min. The concentrations of IL-2 were assayed via an ELISA kit.

3.5.4. HepG2 and MDCK Cells Proliferation Assay

HepG2 cells (4 × 104 cells/mL) and MDCK cells (4 × 104 cells/mL) were plated on 96-well plates, separately. After the cells were incubated for 24 h, the cells were supplemented with serial concentrations of OP-1 and 5-Fu, respectively. Cell culture DMEM medium was used as the control group. Following incubation at 37 °C and 5% CO2, MTT (0.5 mg/mL) was added and co-incubated for an additional 4 h in the dark. After cultivation, the supernatants were removed, and the residues were dissolved with DMSO. The absorbance values were recorded at 570 nm, and the percentage of cell inhibition (%) was calculated from the decrease in absorbance of treated samples as compared with the control cells, which is calculated using the following formula:

Cell inhibition (%) = (AcAs)/Ac × 100%

where Ac is the absorbance value of the control, and As is the absorbance value of the test compound.

3.5.5. Phagocytic Assay

FITC-labeled annexin V was used for the phagocytic assay of HepG2. Cells (4 × 104) were cultured in a 96-well plate with additional OP-1 and 5-Fu for 24 h, respectively. The cell culture medium was used as a blank group. Then, the cells were washed with PBS and then stained with 200 μL of labeling solution containing FITC-labeled annexin V and PI for 10 min at room temperature. An observation was made at a final magnification of 400× using a fluorescence microscope. The phagocytic ability expressed as a mean fluorescence intensity (MFI)-FITC between the cells in treatments group and those of the blank group.

3.6. Statistical Analysis

Data were expressed as mean ± standard errors based on at least three independent experiments for each sample. Statistical significance was calculated via one-way analysis of variance test followed by a least significant difference test. Values of p <0.05 were considered to be statistical significant.

4. Conclusions

A simple and efficient ATPS has been successfully applied to separate oyster polysaccharides and proteins. Under optimum ATPS conditions, polysaccharides were separated in the bottom phase, and the extraction efficiency was 67.02%. This ATPS is a simple, fast, and green separation system that can be used to isolate and purify oyster polysaccharides on a large scale. These polysaccharides (OP-1) consisted of glucose and had an Mw of 3480 Da. OP-1 consisted of a backbone of (1→4)-α-d-glucosyl with α-d-glucosyl residues on the terminal of the side chains at the O-3 position. Moreover, OP-1 can stimulate the phagocytic activity and IL-2 production. OP-1 showed significant anti-tumor activity against HepG2 cells in vitro and had no direct toxicity to normal cells. These results can guide the direction of future research toward novel functional food or therapeutic agents.

Acknowledgments

This research was financially supported by grants from the National Natural Science Foundation of China (21476135), the Educational Commission of Guangdong Province, China (2016KZDXM014), the Ocean and Fisheries Administration Project of Guangdong Province, China (2017), and the Research and Development Start-Up Foundation of Shantou University (NTF16014).

Author Contributions

Kit-Leong Cheong and Li-Xuan Xia performed the experiments and data analysis, and wrote the paper; Yang Liu contributed to the conception and design of the experiments. All authors reviewed the manuscript and approved the final version.

Conflicts of Interest

The authors declare no conflict of interest.

References

  • 1.Watanabe M., Fuda H., Okabe H., Joko S., Miura Y., Hui S.-P., Yimin, Hamaoka N., Miki E., Chiba H. Oyster extracts attenuate pathological changes in non-alcoholic steatohepatitis (NASH) mouse model. J. Funct. Foods. 2016;20:516–531. doi: 10.1016/j.jff.2015.11.029. [DOI] [Google Scholar]
  • 2.Wang Q., Li W., He Y., Ren D., Kow F., Song L., Yu X. Novel antioxidative peptides from the protein hydrolysate of oysters (Crassostrea talienwhanensis) Food Chem. 2014;145:991–996. doi: 10.1016/j.foodchem.2013.08.099. [DOI] [PubMed] [Google Scholar]
  • 3.Watanabe M., Fuda H., Jin S., Sakurai T., Ohkawa F., Hui S.-P., Takeda S., Watanabe T., Koike T., Chiba H. Isolation and characterization of a phenolic antioxidant from the pacific oyster (Crassostrea gigas) J. Agric. Food Chem. 2012;60:830–835. doi: 10.1021/jf2038532. [DOI] [PubMed] [Google Scholar]
  • 4.Achour A., Lachgar A., Astgen A., Chams V., Bizzini B., Tapiero H., Zagury D. Potentialization of IL-2 effects on immune cells by oyster extract (JCOE) in normal and HIV-infected individuals. Biomed. Pharmacother. 1997;51:427–429. doi: 10.1016/S0753-3322(97)82320-7. [DOI] [PubMed] [Google Scholar]
  • 5.Cheng J.Y., Ng L.T., Lin C.L., Jan T.R. Pacific oyster-derived polysaccharides enhance antigen-specific T helper (Th)1 immunity in vitro and in vivo. Immunopharmacol. Immunotoxicol. 2013;35:235–240. doi: 10.3109/08923973.2012.751398. [DOI] [PubMed] [Google Scholar]
  • 6.Itoh N., Kamitaka R., Takahashi K.G., Osada M. Identification and characterization of multiple β-glucan binding proteins in the Pacific oyster, Crassostrea gigas. Dev. Comp. Immunol. 2010;34:445–454. doi: 10.1016/j.dci.2009.12.003. [DOI] [PubMed] [Google Scholar]
  • 7.Shi X., Ma H., Tong C., Qu M., Jin Q., Li W. Hepatoprotective effect of a polysaccharide from Crassostrea gigas on acute and chronic models of liver injury. Int. J. Biol. Macromol. 2015;78:142–148. doi: 10.1016/j.ijbiomac.2015.03.056. [DOI] [PubMed] [Google Scholar]
  • 8.Wang T., Ding J., Li H., Xiang J., Wen P., Zhang Q., Yin L., Jiang W., Shen C. Antihypertensive activity of polysaccharide from Crassostrea gigas. Int. J. Biol. Macromol. 2016;83:195–197. doi: 10.1016/j.ijbiomac.2015.11.078. [DOI] [PubMed] [Google Scholar]
  • 9.Wu S., Huang X. Preparation and antioxidant activities of oligosaccharides from Crassostrea gigas. Food Chem. 2017;216:243–246. doi: 10.1016/j.foodchem.2016.08.043. [DOI] [PubMed] [Google Scholar]
  • 10.Hu X., Tao N., Wang X., Xiao J., Wang M. Marine-derived bioactive compounds with anti-obesity effect: A review. J. Funct. Foods. 2016;21:372–387. doi: 10.1016/j.jff.2015.12.006. [DOI] [Google Scholar]
  • 11.Ferreira S.S., Passos C.P., Madureira P., Vilanova M., Coimbra M.A. Structure–function relationships of immunostimulatory polysaccharides: A review. Carbohydr. Polym. 2015;132:378–396. doi: 10.1016/j.carbpol.2015.05.079. [DOI] [PubMed] [Google Scholar]
  • 12.Cheong K.-L., Meng L.-Z., Chen X.-Q., Wang L.-Y., Wu D.-T., Zhao J., Li S.-P. Structural elucidation, chain conformation and immuno-modulatory activity of glucogalactomannan from cultured Cordyceps sinensis fungus UM01. J. Funct. Foods. 2016;25:174–185. doi: 10.1016/j.jff.2016.06.002. [DOI] [Google Scholar]
  • 13.Shin M.-S., Lee H., Hong H.-D., Shin K.-S. Characterization of immunostimulatory pectic polysaccharide isolated from leaves of Diospyros kaki Thumb. (Persimmon) J. Funct. Foods. 2016;26:319–329. doi: 10.1016/j.jff.2016.07.025. [DOI] [Google Scholar]
  • 14.Liu Y., Feng Y., Lun J. Aqueous two-phase countercurrent distribution for the separation of c-phycocyanin and allophycocyanin from Spirulina platensis. Food Bioprod. Process. 2012;90:111–117. doi: 10.1016/j.fbp.2011.08.002. [DOI] [Google Scholar]
  • 15.Liu X., Mu T., Sun H., Zhang M., Chen J. Optimisation of aqueous two-phase extraction of anthocyanins from purple sweet potatoes by response surface methodology. Food Chem. 2013;141:3034–3041. doi: 10.1016/j.foodchem.2013.05.119. [DOI] [PubMed] [Google Scholar]
  • 16.Li Z., Pei Y., Wang H., Fan J., Wang J. Ionic liquid-based aqueous two-phase systems and their applications in green separation processes. TrAC Trends Anal. Chem. 2010;29:1336–1346. doi: 10.1016/j.trac.2010.07.014. [DOI] [Google Scholar]
  • 17.Ao G., Khripin C.Y., Zheng M. DNA-controlled partition of carbon nanotubes in polymer aqueous two-phase systems. J. Am. Chem. Soc. 2014;136:10383–10392. doi: 10.1021/ja504078b. [DOI] [PubMed] [Google Scholar]
  • 18.Desai R.K., Streefland M., Wijffels R.H., Eppink M.H.M. Extraction and stability of selected proteins in ionic liquid based aqueous two phase systems. Green Chem. 2014;16:2670–2679. doi: 10.1039/C3GC42631A. [DOI] [Google Scholar]
  • 19.Liu Y., Zhang Y., Wu X., Yan X. Effect of excluded-volume and hydrophobic interactions on the partition of proteins in aqueous micellar two-phase systems composed of polymer and nonionic surfactant. Fluid Phase Equilib. 2016;429:1–8. doi: 10.1016/j.fluid.2016.08.026. [DOI] [Google Scholar]
  • 20.Spyropoulos F., Portsch A., Norton I.T. Effect of sucrose on the phase and flow behaviour of polysaccharide/protein aqueous two-phase systems. Food Hydrocoll. 2010;24:217–226. doi: 10.1016/j.foodhyd.2009.09.008. [DOI] [Google Scholar]
  • 21.Rajendran V., Puvendran K., Guru B.R., Jayaraman G. Design of aqueous two-phase systems for purification of hyaluronic acid produced by metabolically engineered Lactococcus lactis. J. Sep. Sci. 2016;39:655–662. doi: 10.1002/jssc.201500907. [DOI] [PubMed] [Google Scholar]
  • 22.Xing J.-M., Li F.-F. Purification of aloe polysaccharides by using aqueous two-phase extraction with desalination. Nat. Prod. Res. 2009;23:1424–1430. doi: 10.1080/14786410902800657. [DOI] [PubMed] [Google Scholar]
  • 23.Wang Y., Hu X., Han J., Ni L., Tang X., Hu Y., Chen T. Integrated method of thermosensitive triblock copolymer–salt aqueous two phase extraction and dialysis membrane separation for purification of lycium barbarum polysaccharide. Food Chem. 2016;194:257–264. doi: 10.1016/j.foodchem.2015.08.016. [DOI] [PubMed] [Google Scholar]
  • 24.Tao Y., Zhang L., Yan F., Wu X. Chain conformation of water-insoluble hyperbranched polysaccharide from fungus. Biomacromolecules. 2007;8:2321–2328. doi: 10.1021/bm070335+. [DOI] [PubMed] [Google Scholar]
  • 25.Zhang W., Li P., Song D., Niu H., Shi S., Wang S., Duan J. Structural characterization and biological activities of two α-glucans from Radix Paeoniae Alba. Glycoconj. J. 2016;33:147–157. doi: 10.1007/s10719-015-9647-x. [DOI] [PubMed] [Google Scholar]
  • 26.Bittencourt V.C.B., Figueiredo R.T., Silva R.B.D., Mourãosá D.S., Fernandez P.L., Sassaki G.L., Mulloy B., Bozza M.T., Barretobergter E. An α-glucan of Pseudallescheria boydii is involved in fungal phagocytosis and toll-like receptor activation. J. Biol. Chem. 2006;281:22614–22623. doi: 10.1074/jbc.M511417200. [DOI] [PubMed] [Google Scholar]
  • 27.Liu D., Liao N., Ye X., Hu Y., Wu D., Guo X., Zhong J., Wu J., Chen S. Isolation and structural characterization of a novel antioxidant mannoglucan from a marine bubble snail, Bullacta exarata (Philippi) Mar. Drugs. 2013;11:4464–4477. doi: 10.3390/md11114464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Jiang C., Wang M., Liu J., Gan D., Zeng X. Extraction, preliminary characterization, antioxidant and anticancer activities in vitro of polysaccharides from Cyclina sinensis. Carbohydr. Polym. 2011;84:851–857. doi: 10.1016/j.carbpol.2010.11.027. [DOI] [Google Scholar]
  • 29.Zhang H., Ye L., Wang K. Structural characterization and anti-inflammatory activity of two water-soluble polysaccharides from Bellamya purificata. Carbohydr. Polym. 2010;81:953–960. doi: 10.1016/j.carbpol.2010.04.011. [DOI] [Google Scholar]
  • 30.Zhang M., Cui S.W., Cheung P.C.K., Wang Q. Antitumor polysaccharides from mushrooms: A review on their isolation process, structural characteristics and antitumor activity. Trends Food Sci. Technol. 2007;18:4–19. doi: 10.1016/j.tifs.2006.07.013. [DOI] [Google Scholar]
  • 31.Mayakrishnan V., Kannappan P., Abdullah N., Ahmed A.B.A. Cardioprotective activity of polysaccharides derived from marine algae: An overview. Trends Food Sci. Technol. 2013;30:98–104. doi: 10.1016/j.tifs.2013.01.007. [DOI] [Google Scholar]
  • 32.DuBois M., Gilles K.A., Hamilton J.K., Rebers P.T., Smith F. Colorimetric method for determination of sugars and related substances. Anal. Chem. 1956;28:350–356. doi: 10.1021/ac60111a017. [DOI] [Google Scholar]
  • 33.Ciucanu I., Kerek F. A simple and rapid method for the permethylation of carbohydrates. Carbohydr. Res. 1984;131:209–217. doi: 10.1016/0008-6215(84)85242-8. [DOI] [Google Scholar]

Articles from Marine Drugs are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES